p53as protein and antibody therefor

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 723, 5303877, 5303888, 53038885, 5303897, G01N 3353, G01N 33577, C07K 1618, C07K 1630

Patent

active

057260249

ABSTRACT:
The invention comprises plasmids and viral vectors containing an animal p53as cDNA sequence. A portion of the p53as sequence may be identified to a position of wild type p53 gene from the same animal. In preferred embodiments, the p53as is mouse or human p53as. A preferred viral vector is baculovirus vector. The invention further includes antibodies both polyclonal and monoclonal, to p53as and to at least a portion of human p53 intron 10 sequence encoding SLRPFKALVREKGHRPSSHSC (SEQ ID NO: 1) which is related to p53as sequences and plasmids and viral vectors containing such sequences. All of the above find utility in studying p53 and p53as and their relative expressions which is believed important for detection and control of malignant cells and their susceptibility to treatment agents. The antibodies can detect the presence of p53as and related sequences and when injected into cells could cause cell cycle arrest and the plasmids and viral vectors, with appropriate promotors, can cause expression of the p53as and p53 intron 10 sequences which can affect cell growth and perhaps arrest certain malignancies.

REFERENCES:
patent: 4786718 (1988-11-01), Weinberg et al.
Antibodies--Anti-Oncogenes--p53 and Heat Shock Proteins, Oncogene Science.
Arai, N. et al., (1986) Immunologically Distinct p53 Molecules Generated by Alternative Splicing, Mol. and Cellular Biology, pp. 3232-3239.
Barak, Y. et al., (1993) mdm2 Expression is Induced by Wild Type p53 Activity, The EMBO Journal, vol. 12, No. 2, pp. 461-468.
Bargonetti, J. et al., (1991) Wild-Type but not Mutant p53 Immunopurified Proteins Bind to Sequences Adjacent to the SV40 Origin of Replication, Cell, vol. 65, pp. 1083-1091.
Bargonetti, J. et al. (1993) A Proteolytic Fragment From the Central Region of p53 Has Marked Sequence-Specific DNA-Binding Activity When Generated from Wild-Type but not from Oncogenic Mutant p53 Protein, Genes & Development, 7, pp. 2565-2574.
Bischoff, J. et al., (1992) Human p53 Inhibits Growth in Schizosaccharomyces pombe, Molecular and Cellular Biology, vol. 12, No. 4, pp. 1405-1411.
El-Deiry, W. et al., (1993) WAF12, A Potential Mediator of p53 Tumor Suppression, Cell, vol. 75, pp. 817-825.
El-Deiry, W. et al. (1992) Definition of a Consensus Binding Site for p53, Nature Genetics, vol. 1, pp. 45-49.
Eliyahu et al., (1988) Meth A Fibrosarcoma Cells Express Two Transforming Mutant p53 Species, Oncogene, 3, pp. 313-321.
Farmer, G. et al., (1992) Wild-type p53 Activates Transcription in vitro, Nature, vol. 358, pp. 83-86.
Finlay, C. et al., (1993) The mdm-2 Oncogene Can Overcome Wild-Type 53 Suppression of Transformed Cell Growth, Mol. & Cell. Biol., pp. 301-306.
Friedman, P. et al., (1993) The p53 Proteins is an Unusually Shaped Tetramer that Binds Directly to DNA, Proc. Natl. Acad. Sci. USA, vol. 90, pp. 3319-3323.
Funk, W. et al., (1992) A Transcriptionally Active DNA-Binding Site for Human p53 Protein Complexes, Mol. and Cell. Biol., pp. 2866-2871.
Gannon J. et al., (1990) Activating Mutations in p53 Produce a Common Conformational Effect, A Monoclonal Antibody Specific for the Mutant Form, The EMBO Journal, vol. 9, No. 5, pp. 1595-1602.
Gu, Y. et al., (1993) Inhibition of CDK2 Activity in vivo by an Associated 20K Regulatory Subunit, Nature, vol. 366, pp. 707-710.
Gupta R. K. et al., (1993) Mutation of p53 in Primary Biopsy Material and Cell Lines From Hodgkin Disease, Proc. Natl. Acad. Sci., vol. 90, pp. 2817-2821.
Hainaut, P. et al., (1992) Interaction of Heat-Shock Protein 70 with p53 Translated in vitro: Evidence for Interaction with Dimeric p53 and for a Role in the Regulation of p53 Conformation, The EMBO Journal, vol. 11, No. 10, pp. 3513-3520.
Halazonetis, T. et al., (1993) Wild-Type p53 Adopts a "Mutant"-Like Conformation When Bound to DNA, The EMBO Journal, vol. 12, No. 3, pp. 1021-1028.
Han, K. et al., (1992) Alternatively Spliced p53 RNA in Transformed and Normal Cells of Different Tissue Types, Nuc. Acid Res. vol. 20, No. 8, pp. 1979-1981.
Harper, J. et al., (1993) The p21 Cdk-Interacting Protein Cip1 is a Potent Inhibitor of G1 Cyclin-Dependent Kinases, Cell, vol. 75, pp. 805-816.
Hupp, T. et al., (1992) Regulation of the Specific DNA Binding Function of p53, Cell, vol. 71, pp. 875-886.
Juven, T. et al. (1993) Wild Type p53 Can Mediate Sequence-Specific Transactivation of an Internal Promoter Within the mdm2 Gene, Oncogene, 8, pp. 3411-3416.
Kastan, M. et al., (1991) Participation of p53 Protein in the Cellular Response to DNA Damage, Cancer Research, 51, pp. 6304-6311.
Kastan, M. et al., (1992) A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective in Ataxia-Telangiectasia, Cell, vol. 71, pp. 587-597.
Kern, S. et al. (1992) Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression, Science, vol. 256, pp. 827-830.
Kern, S. et al., (1991) Identification of p53 as a Sequence-Specific DNA-Binding Protein, Science, vol. 252, pp. 1708-1711.
Kuerbitz, S. et al., (1992) Wild-Type p53 is a Cell Cycle Checkpoint Determinant Following Irradiation, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 7491-7495.
Kulesz-Martin, M. et al., Endogenous p53 Protein Generated from Wild-Type Alternatively Spliced p53 RNA in Mouse Epidermal Cells, Molecular and Cellular Biology, vol. 14, pp. 1698-1708.
Lane, D. (1992) p53, Guardian of the Genome, Nature, vol. 358, pp. 15-16.
Milner, J. et al., (1991) Cotranslation of Activated Mutant p53 with Wild Type Drives the Wild-Type p53 Protein into the Mutant Conformation, Cell, vol. 65, pp. 765-774.
Momand, J. et al., (1992) The mdm-2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation, Cell, vol. 69, pp. 1237-1245.
Nigro, J. et al., (1992) Human p53 and CDC2Hs Genese Combine to Inhibit the Proliferation of Saccharomyces cerevisiae, Molecular and Cellular Biology, pp. 1357-1365.
Oliner, J. et al., (1992) Amplification of a Gene Encoding a p53-Associated Protein in Human Sarcomas, Nature, vol. 358, pp. 80-83.
Pavletich, N. et al. (1993) The DNA-Binding Domain of p53 Contains the Four Conserved Regions and the Major Mutation Hot Spots, Genes & Development, 7, pp. 2556-2564.
Ro, Y.S. et al., (1993) p53 Protein Expression in Benign and Malignant Skin Tumours, British Journal of Dermatology, 128, 237-241.
Scharer, E. et al. (1992) Mammalian p53 Can Function as a Transcription Factor in Yeast, Nucleic Acids Research, vol. 20, No. 7, pp. 1539-1545.
Serrano, J. et al., (1993) A New Regulatory Motif in Cell-Cycle Control Causing Specific Inhibition of Cyclin D/CDK4, Nature, vol. 366, pp. 704-707.
Stenger, J. et al., (1992) Formation of Stable p53 Homotetramers and Multiples of Tetramers, Molecular Carcinogenesis, 5, pp. 102-106.
Stephen, C. et al., (1992) Mutant Conformation of p53, J. Mol. Biol., 225, pp. 577-583.
Vojtesek, B. et al. (1992) An Immunochemical Analysis of the Human Nuclear Phosphoprotein p53, Journal of Immunological Methods, 151, pp. 237-244.
Wade-Evans, A. et al. (1985) Precise Epitope Mapping of the Murine Transformation-Associated Protein, p53, The EMBO Journal, vol. 4, No. 3, pp. 699-706.
Wang, Y. et al. (1993) p53 Domains: Identification and Characterization of Two Autonomous DNA-Binding Regions, Genes & Development, 7, pp. 2575-2586.
Wolf, D. et al., (1985) "Isolation of a Full-Length Mouse cDNA Clone Coding for an Immunologically Distinct p53 Molecule", Molecular and Cellular Biology, vol. 5, #1, pp. 127-132.
Xlong, Y. et al., (1993) p21 is a Universal Inhibitor of Cyclin Kinases, Nature vol. 366, pp. 701-704.
Zambetti, G. et al., (1992) Wild-Type p53 Mediates Positive Regulation of Gene Expression Through a Specific DNA Sequence Element, Genes & Development, 6, pp. 1143-1152.
Zauberman, A. et al. (1993) Sequence-Specific DNA Binding by p53: Identification of Target Sites and Lack of Binding to p53-MDM2 Complexes, The EMBO Journal, vol. 12, No. 7, pp. 2799-2808.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

p53as protein and antibody therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with p53as protein and antibody therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and p53as protein and antibody therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-138345

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.